MASCC/ISOO clinical practice statement: Current understanding on controversies in basic oral care in hemato-oncology and hematopoietic cell transplantation

Judith E. Raber-Durlacher*, Yehuda Zadik, Nathaniel S. Treister, Noa Stempler, Julia S. Bruno, Joel B. Epstein, Sharon Elad

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Purpose: A MASCC/ISOO Clinical Practice Statement (CPS) is aimed at generating a concise tool for clinicians, which concentrates on practical information needed for the management of oral complications of cancer patients. This CPS is focused on the current understanding of controversies that may arise while providing basic oral care in hemato-oncology patients and hematopoietic cell transplantation recipients (HCT). The CPS will summarize and elucidate controversies that have appeared in the literature and professional discussions. Methods: This CPS was developed based on a critical evaluation of the literature followed by a structured discussion of a group of leading experts, members of the Oral Care Study Group of MASCC/ISOO. The information is presented in the form of succinct bullets to generate a short manual about the best standard of care. Results: Controversies about the use of chlorhexidine (CHX) oral rinse, mechanical dental plaque removal procedures, the need for toothbrush replacement during phases of low blood cell counts, and the use of lidocaine mouthwash for oral pain were identified and discussed. Consensus about the best standard of care was outlined. Conclusion: The following ratifications are applicable for oral care in hemato-oncology patients and patients undergoing HCT: (1) CHX may reduce the risk of oral infections, although it was not found to reduce the risk of oral mucositis. (2) Toothbrushing and proficient interproximal cleaning should not be discouraged during HCT. (3) Toothbrushes do not need to be replaced daily and are preferred over cleansing swabs. (4) Lidocaine rinse, swish and spit, may be considered to palliate oral mucosal pain if applied in a certain manner.

Original languageEnglish
Article number550
JournalSupportive Care in Cancer
Volume32
Issue number8
DOIs
StatePublished - Aug 2024

Bibliographical note

Publisher Copyright:
© The Author(s) 2024.

Keywords

  • Basic oral care
  • Controversies
  • Hematologic malignancies
  • Hematopoietic cell transplantation
  • Oral complications

Fingerprint

Dive into the research topics of 'MASCC/ISOO clinical practice statement: Current understanding on controversies in basic oral care in hemato-oncology and hematopoietic cell transplantation'. Together they form a unique fingerprint.

Cite this